Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndianapolis-based WellPoint Inc. has put its pharmacy benefits-management business up for sale, according to a report in today’s Financial Times.
The London-based business newspaper, citing sources familiar with the matter, said the business could be worth more than $1 billion and as much as $5 billion.
A WellPoint spokeswoman told the newspaper that the company would not comment on merger speculation but it expects further consolidation in the industry.
WellPoint’s pharmacy benefits-management business is likely to attract interest from CVS Caremark Corp, Medco Health Solutions Inc. and Express Scripts Inc., the Financial Times said.
The sale process has been under way for months, the paper said, citing people close to the matter.
The PBM unit, which includes NextRx, is the fourth largest in the nation, according to the newspaper. NextRx is a third-party administrator that processes prescription drug claims and helps establish drug prices and availability for more than 32 million people insured through WellPoint health plans.
Please enable JavaScript to view this content.